The US Contraceptive Devices Market size was valued at USD 5.9 Billion in 2023 and the total US Contraceptive Devices revenue is expected to grow at a CAGR of 6.21% from 2024 to 2030, reaching nearly USD 8.9 Billion.US Contraceptive Devices Market Overview-
This report analyses the US Contraceptive Devices market and covers trends, technological advancements, and potential disruptions that shape the market. It assesses market size, growth, economic factors, regulations, and commercial drivers. The competitive landscape is analyzed, highlighting differentiation among key operators and drawing on historical data, industry insights, and the report forecasts sector. The economic downturn prompted this analysis and revealed the US Contraceptive Devices industry's resilience challenges. The US Contraceptive Devices market prevalence and incidence rates are steadily increasing. Current statistics by MMR reveal, that in 2023, the prevalence of contraceptive use among women aged 15-44 in the United States has shown an increase in demand, reaching an estimated 65.1%, compared to 60.6% in 2021-22. Highly effective reversible methods (HERMs), such as intrauterine devices (IUDs) and implants, have gained popularity, with usage rising from 13.3% to 17.7% during the same period. Although oral contraceptives remain a common choice, their use has slightly declined from 14.9% to 13.9%. Sterilization procedures, though less frequent, are still opted for by approximately 7.4% of women. The report aims to equip stakeholders with crucial, concise information for informed decision-making in this dynamic sector. The targeted audiences include People with Healthcare professionals, Secondary Audiences, Government agencies, policymakers, and pharmaceutical companies in the US Contraceptive Devices industry.To know about the Research Methodology :- Request Free Sample Report Increased awareness of family planning and sexual health Impact on the US Contraceptive Devices Market The increasing awareness of family planning and sexual health is particular to intricately influence the US Contraceptive Devices market. The positive outcomes include an upswing in contraceptive demand, encompassing established methods and innovative options. The shift towards more effective measures, such as Long-Acting Reversible Contraceptives (LARCs), increased US Contraceptive Devices market dynamics. Additionally, a focus on personalized care and open discussions spur tailored contraceptive recommendations, potentially curbing unintended pregnancies and indirectly impacting healthcare costs related to pregnancy and childbirth. The negative impacts include a continued decline in US birth rates, affecting industries reliant on population growth. Also, political and religious opposition to family planning discussions results in restrictions on contraceptive access and educational initiatives, impacting US Contraceptive Devices industry growth. The unequal access influenced by cost and insurance limitations, hinders market potential despite increased awareness.
The greater awareness of family planning and sexual health is expected to positively influence the US Contraceptive Devices market. Outcomes pivot on factors like awareness campaign strategies, shifts in healthcare policies, and individual preferences.
Impact of Government Initiatives and Policies on the US Contraceptive Devices Market
Initiative/Policy Impact on US Contraceptive Devices Market Market Segment Affected Affordable Care Act (ACA) Contraceptive Mandate Increased Affordability and Access All Segments with a greater impact on Cost-Sensitive Users Medicaid Development Improved Access All Segments with Greater Impact on Low-Income Users Title X Family Planning Program Financial Support and Infrastructure All Segments with greater impact on Underserved Populations Public Health Initiatives Increased Knowledge and Education All Segments Policy Debates and Restrictions Market Uncertainty and Access Challenges All Segments with greater impact on Vulnerable Populations US Contraceptive Devices Market Segment Analysis
Based on Type, the Condoms segment held the largest market share of about 45% in the US Contraceptive Devices Market in 2023. According to the MMR analysis, the segment is further expected to grow at a CAGR of 3.2% during the forecast period. It stands out as the dominant segment within the US Contraceptive Devices Market thanks to its rapid technological advancement and growing adoption of smart devices with data connectivity and integration.Condoms play a significant role in affordable contraception, especially for those with financial constraints, contributing to reproductive health equity. Also, with dual protection against pregnancy and STIs, including HIV/AIDS, they positively impact sexual health outcomes. The steady demand for condoms provides stability to the US Contraceptive Devices market and acts as a reliable segment amid fluctuations. Additionally, their popularity fuels innovation and drives advancements in design and materials as well as benefiting the entire US Contraceptive Devices industry. Also, challenges such as user errors leading to unintended pregnancies, social stigma hindering regular use, and environmental concerns in latex production highlight the need for continuous improvement and exploration of sustainable alternatives in condom technology.
US Contraceptive Devices Market Scope: Inquiry Before Buying
US Contraceptive Devices Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: US $ 5.9 Bn. Forecast Period 2024 to 2030 CAGR: 6.21% Market Size in 2030: US $ 8.9 Bn. Segments Covered: by Type Condoms Diaphragms Cervical Caps Sponges Vaginal Rings Intra Uterine Devices (IUD) Other Devices by Gender Male Female Leading Key Players in the US Contraceptive Devices Market
1. Bayer AG 2. Merck & Co., Inc. 3. CooperSurgical, Inc. 4. Church & Dwight Co., Inc. 5. Reckitt Benckiser Group plc 6. The Female Health Company 7. Allergan plc 8. HLL Lifecare Limited 9. Pregna International Limited 10. AbbVie (Allergan PLC)
1. US Contraceptive Devices Market Introduction 1.1 Study Assumption and Market Definition 1.2 Scope of the Study 1.3 Executive Summary 2. US Contraceptive Devices Market Overview 2.1 Emerging Technologies 2.2 Market Projections 2.3 Strategic Recommendations 3. US Contraceptive Devices Market: Dynamics 3.1.1 Market Drivers 3.1.2 Market Restraints 3.1.3 Market Opportunities 3.1.4 Market Challenges 3.2 PORTER’s Five Forces Analysis 3.3 PESTLE Analysis 3.4 Value Chain Analysis 3.5 Regulatory Landscape 3.6 Analysis of Government Schemes and Initiatives for the US Contraceptive Devices Industry 3.7 The Pandemic and Redefining of The US Contraceptive Devices Industry Landscape 4. US Contraceptive Devices Market: Market Size and Forecast by Segmentation (Value) (2023-2030) 4.1 US Contraceptive Devices Market Size and Forecast, by Type (2023-2030) 4.1.1 Condoms 4.1.2 Diaphragms 4.1.3 Cervical Caps 4.1.4 Sponges 4.1.5 Vaginal Rings 4.1.6 Intra Uterine Devices (IUD) 4.1.7 Other Devices 4.2 US Contraceptive Devices Market Size and Forecast, by Gender (2023-2030) 4.2.1 Male 4.2.2 Female 5. US Contraceptive Devices Market: Competitive Landscape 5.1 MMR Competition Matrix 5.2 Competitive Landscape 5.3 Key Players Benchmarking 5.3.1 Company Name 5.3.2 Service Segment 5.3.3 End-user Segment 5.3.4 Revenue (2023) 5.3.5 Company Locations 5.4 Leading US Contraceptive Devices Companies, by market capitalization 5.5 Market Structure 5.5.1 Market Leaders 5.5.2 Market Followers 5.5.3 Emerging Players 5.6 Mergers and Acquisitions Details 6. Company Profile: Key Players 6.1 Bayer AG 6.1.1 Company Overview 6.1.2 Business Portfolio 6.1.3 Financial Overview 6.1.4 SWOT Analysis 6.1.5 Strategic Analysis 6.1.6 Scale of Operation (small, medium, and large) 6.1.7 Details on Partnership 6.1.8 Regulatory Accreditations and Certifications Received by Them 6.1.9 Awards Received by the Firm 6.1.10 Recent Developments 6.2 Merck & Co., Inc. 6.3 CooperSurgical, Inc. 6.4 Church & Dwight Co., Inc. 6.5 Reckitt Benckiser Group plc 6.6 The Female Health Company 6.7 Allergan plc 6.8 HLL Lifecare Limited 6.9 Pregna International Limited 6.10 AbbVie (Allergan PLC) 7. Key Findings 8. Industry Recommendations 9. Terms and Glossary 10. US Contraceptive Devices Market: Research Methodology